The JEC study confirmed that slow‐metabolizing ADH1B was a predictor of the development of metachronous esophageal SCC after ER and inactive ALDH2 was also associated with the development of metachronous esophageal SCC.19 The gene discussed is ALDH2; the disease is esophageal squamous cell carcinoma.